Arteris, INC

Market Movers (8-K)

See all →
NASDAQ
Arteris, Inc. announced the appointment of Saurabh Sinha as its new Chief Financial Officer, effective September 8, 2026, succeeding Nick Hawkins.
NASDAQ
Arteris, Inc. successfully concluded its 2026 Annual Meeting of Stockholders, confirming the election of three directors and the ratification of its independent auditor.
NASDAQ
Arteris, Inc. reported a robust first quarter for 2026 with record ACV plus royalties and significant year-over-year revenue growth, alongside the announcement of its CFO's upcoming retirement.
NASDAQ
Arteris, Inc. announced strong Q4 and full-year 2025 financial results, including record ACV plus royalties and RPO, alongside strategic acquisitions and partnerships.
Better than expected
NASDAQ
Arteris, Inc. is set to acquire Cycuity, Inc. in a two-step merger for up to $45 million, comprising cash and Arteris common stock, with an earnout tied to 2026 bookings.
NASDAQ
Arteris, Inc. announced strong third-quarter 2025 financial results, including record Annual Contract Value plus royalties and Remaining Performance Obligations, while providing updated full-year guidance.
Better than expected

Quarterly Earnings (10-Q)

See all →
NASDAQ
Arteris, Inc. reported a 46% increase in revenue for Q2 2026 compared to the prior year, driven by new customers and the Cycuity acquisition, but also saw a significant rise in operating expenses and net loss.
Capital raise
Worse than expected
NASDAQ
Arteris, Inc. reported a net loss of $7.96 million for the first quarter of 2026, with total revenue increasing by 39% year-over-year, driven by new customer acquisitions and the integration of Cycuity.
Capital raise
Worse than expected
NASDAQ
Arteris, Inc. announced an 18% revenue increase for Q3 2025, driven by new customer agreements and royalties, despite a widening net loss.
Capital raise
Worse than expected
NASDAQ
Arteris, Inc. reported a 13% increase in second-quarter revenue to $16.5 million, driven by new license agreements and royalty growth, though net loss widened to $9.1 million.
Capital raise
Worse than expected
NASDAQ
Arteris, Inc. announced a 28% increase in revenue for the first quarter of 2025, primarily driven by growth in licensing, support, and maintenance revenue.
NASDAQ
Arteris Inc. saw a revenue increase in Q3 2024 compared to Q3 2023, but still reported a net loss for the quarter.
Worse than expected

Annual Reports (10-K)

NASDAQ
Arteris, Inc. reported a 22% increase in total revenue to $70.6 million for fiscal year 2025, alongside a net loss of $34.7 million, as it continues significant R&D investments and strategic acquisitions.
Capital raise
Worse than expected
NASDAQ
Arteris, Inc. reports increased revenue and Annual Contract Value (ACV) for fiscal year 2024, while still incurring a net loss as it invests in future growth.
NASDAQ
Arteris, Inc. reports a revenue increase to $53.7 million for 2023, alongside a net loss of $36.9 million, while also adding 23 net new active customers.
Worse than expected

Insider Trading (Form 4)

See all →
NASDAQ
Nicholas B. Hawkins, VP and Chief Financial Officer of Arteris, Inc., sold 10,631 shares of common stock on August 12, 2026.
NASDAQ
Bayview Legacy, LLC reported changes in beneficial ownership of Arteris, Inc. common stock on August 3, 2026.
NASDAQ
Saiyed Atiq Raza, a Director of Arteris, Inc., sold 70,000 shares of common stock on August 3, 2026.
NASDAQ
Paul L Alpern, VP and General Counsel of Arteris, Inc., sold 4,000 shares of common stock on August 3, 2026.
NASDAQ
K Charles Janac, President and CEO, a Director and 10% owner of Arteris, Inc., sold 100,000 shares of common stock on August 3, 2026.
NASDAQ
Arteris, Inc. reports significant stock sales by President and CEO K. Charles Janac, executed under a pre-arranged 10b5-1 trading plan.

Proxy Statements (Def-14A)

NASDAQ
Arteris, Inc. announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026, focusing on director elections and auditor ratification.
NASDAQ
Arteris, Inc. will hold its annual stockholders meeting virtually on June 3, 2025, to elect directors and ratify the appointment of Deloitte & Touche LLP as its independent auditor.
NASDAQ
Arteris, Inc. invites stockholders to its 2025 Annual Meeting, reflecting on revenue growth to $57.7M and expansion in key markets.
NASDAQ
Arteris, Inc. will hold its annual meeting of stockholders on June 4, 2024, to elect directors and ratify the appointment of Deloitte & Touche LLP as the company's independent auditor.
NASDAQ
Arteris, Inc. has released its proxy statement for the 2024 Annual Meeting of Stockholders, detailing proposals for director elections and auditor ratification.

Schedule 13G - Passive Investments

NASDAQ
Needham Investment Management and related entities have reported a combined beneficial ownership of 7.8% in Arteris, Inc. common stock as of September 30, 2025.